Effects of dose modifications on the safety and efficacy of dacomitinib for mutation-positive non-small-cell lung cancer

  1. Corral, J.
  2. Mok, T.S.
  3. Nakagawa, K.
  4. Rosell, R.
  5. Lee, K.H.
  6. Migliorino, M.R.
  7. Pluzanski, A.
  8. Linke, R.
  9. Devgan, G.
  10. Tan, W.
  11. Quinn, S.
  12. Wang, T.
  13. Wu, Y.-L.
Revue:
Future Oncology

ISSN: 1744-8301,  1479-6694

Année de publication: 2019

Volumen: 15

Número: 24

Pages: 2795-2805

Type: Article

DOI: 10.2217/FON-2019-0299 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus